65 results on '"A, Savignoni"'
Search Results
2. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study
3. Impact of body mass index on overall survival in patients with metastatic breast cancer
4. A Question Prompt List for Advanced Cancer Patients Promoting Advance Care Planning: A French Randomized Trial
5. Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
6. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
7. Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
8. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy
9. Randomized trials: When scientific rigor meets field reality
10. Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003
11. Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003
12. Functional residual capacity and lung clearance index in infants treated for esophageal atresia and tracheoesophageal fistula
13. Fine Needle Aspiration Biopsy in Uveal Melanoma: Technique, Complications, and Outcomes
14. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial
15. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)
16. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma
17. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer
18. Functional residual capacity (FRC) and lung clearance index (LCI) in mechanically ventilated infants: Application in the newborn with congenital diaphragmatic hernia (CDH)
19. 319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC)
20. Galeazzi’s modified technique for recurrent patella dislocation in skeletally immature patients
21. Mesothelioma at era of helical tomotherapy: Results of two institutions in combining chemotherapy, surgery and radiotherapy
22. Traitement locorégional du cancer du sein inflammatoire après chimiothérapie néoadjuvante
23. Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?
24. The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: A single-institution study
25. The impact of the loco-regional treatment in elderly breast cancer patients: Hypo-fractionated exclusive radiotherapy, single institution long-term results
26. Évaluation monocentrique de la tolérance de l’association concomitante de trastuzumab et de radiothérapie
27. La radiothérapie mammaire hypofractionnée en 13 séances, parfaite tolérance ou réaction cutanée décalée ? Étude prospective de l’institut Curie
28. Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
29. Phyllodes tumors of the breast segregate in two groups according to genetic criteria
30. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (
31. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy
32. Migration des grains d'iode 125 après curiethérapie prostatique : étude d'une série de 170 patients
33. Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with Pentamidine
34. 367P - Prognostic impact of body mass index (BMI) on overall survival in patients with metastatic breast cancer
35. 220P - Sefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study
36. Traitement conservateur dans la prise en charge locorégionale du cancer du sein après lymphome de Hodgkin
37. Helical tomotherapy for resected malignant pleural mesothelioma: Dosimetric evaluation and toxicity
38. Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS)
39. Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network
40. 451 Locoregional treatment of inflammatory breast cancer after neoadjuvant chemotherapy
41. 357 Tolerance of concurrent adjuvant trastuzumab and radiotherapy, involving in most cases the internal mammary chain, for breast cancer: results from a prospective study
42. 317 Predictive factors of negative axillary dissection after neoadjuvant chemotherapy (NAC): place of a score in decision-making regarding sentinel lymph node after NAC in patients with locally advanced breast cancer
43. 247 Is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?
44. 183 A DNA signature to identify high-risk small node-negative breast cancer patients
45. 128 Locoregional recurrences in triple-negative, node-negative early stage breast cancer treated with breast-conserving treatment
46. 113 Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long term results and review of the literature
47. Résultats à long terme de la radiothérapie mammaire hypofractionnée comme traitement exclusif des patientes âgées souffrant d’un cancer du sein
48. Tolérance cutanée de l’association d’inhibiteurs de l’aromatase et d’une radiothérapie mammaire hypofractionnée
49. La tomothérapie hélicoïdale des cancers ORL : évaluation scintigraphique prospective de la préservation des glandes parotides
50. CL102 - Intérêt du dépistage précoce dans les formes familiales de rétinoblastome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.